Published in J Natl Cancer Inst on September 01, 1978
Recovery of humoral and cellular immunity by soluble mediators after 5-fluorouracil-induced immunosuppression. Clin Exp Immunol (1982) 0.78
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res (2000) 1.96
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog (1999) 1.95
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res (2000) 1.84
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res (1996) 1.77
Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr (2000) 1.69
Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst (1990) 1.56
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci U S A (2000) 1.54
Fetal choroid plexus cysts in the second trimester of pregnancy: a cause for concern. Am J Obstet Gynecol (1991) 1.53
Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev (1999) 1.49
The isolated choroid plexus cyst. Obstet Gynecol (1998) 1.38
Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys (1985) 1.28
Effects of sublethal gamma radiation on T and B cell activity in the antibody response of mice. Radiat Res (1976) 1.23
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res (2000) 1.12
Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res (1999) 1.10
Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis (2001) 1.10
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res (2000) 1.07
Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis (1999) 1.07
Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochemistry (1993) 1.04
Chemoprevention of prostate cancer: concepts and strategies. Eur Urol (1999) 1.04
Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl (1994) 1.03
Cervical teratoma: prenatal diagnosis and long-term follow-up. Prenat Diagn (1998) 1.02
Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis (1996) 1.01
New agents for cancer chemoprevention. J Cell Biochem Suppl (1996) 1.00
Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res (1998) 0.99
Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Cancer Res (1999) 0.97
The effect of vitamin E acetate on ultraviolet-induced mouse skin carcinogenesis. Mol Carcinog (1998) 0.96
Progress in cancer chemoprevention. Ann N Y Acad Sci (1999) 0.95
Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis (1999) 0.95
Prenatal diagnosis--when and how? N Engl J Med (1992) 0.95
Bioavailability of selenium accumulated by selenite-reducing bacteria. Biol Trace Elem Res (1996) 0.94
Strategy and planning for chemopreventive drug development: clinical development plans II. J Cell Biochem Suppl (1996) 0.94
Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. Cancer Res (1999) 0.94
Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis (1999) 0.92
Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents. Cancer Res (1999) 0.92
Biological effects of the Sudan dyes. Role of the Ah cytosolic receptor. Biochem Pharmacol (1983) 0.92
Measurement of cytochrome P-450 dependent dealkylation of alkoxyphenoxazones in hepatic S9s and hepatocyte homogenates: effects of dicumarol. Mutat Res (1985) 0.91
Fetal foot length: relationship to menstrual age and fetal measurements in the second trimester. Obstet Gynecol (1988) 0.91
A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Oncogene (2006) 0.91
Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives. Biochemistry (1992) 0.90
Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours. Eur J Cancer (2003) 0.90
Formation and persistence of nucleotide alterations in rats exposed whole-body to environmental cigarette smoke. Carcinogenesis (1999) 0.90
5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model. Carcinogenesis (1999) 0.90
Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev (1996) 0.89
Dibenz[a,h]anthracene-induced subcutaneous tumors in mice. Strain sensitivity and the role of carcinogen metabolism. Carcinogenesis (1983) 0.89
Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol (1993) 0.89
Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res (2001) 0.88
K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis (1995) 0.88
Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice. Exp Lung Res (2000) 0.88
Risk biomarkers and current strategies for cancer chemoprevention. J Cell Biochem Suppl (1996) 0.87
Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis. Gastroenterology (2004) 0.86
Aromatase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev (1998) 0.85
Preferential decrease in thymus dependent lymphocytes during storage at 4 C in anticoagulant. Transfusion (1977) 0.85
Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland. Cancer Res (1996) 0.85
Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute. J Cell Biochem Suppl (1994) 0.85
Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats. Carcinogenesis (1997) 0.84
Induction of cytochrome P-450 in the Norway rat, Rattus norvegicus, following exposure to potential environmental contaminants. J Toxicol Environ Health (1995) 0.84
Mosaic trisomy 16 ascertained through amniocentesis: evaluation of 11 new cases. Am J Med Genet (1998) 0.84
Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J Cell Biochem Suppl (1997) 0.83
Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer. Urology (2001) 0.83
Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction. Am J Obstet Gynecol (1992) 0.83
Chemical enhancement of SA7 virus transformation of hamster embryo cells: evaluation by interlaboratory testing of diverse chemicals. Environ Mutagen (1986) 0.83
Preclinical drug development paradigms for chemopreventives. Hematol Oncol Clin North Am (1998) 0.83
Chemopreventive efficacy of promising farnesyltransferase inhibitors. Exp Lung Res (2000) 0.83
Effect of the aromatase inhibitor vorozole on estrogen and progesterone receptor content of rat mammary carcinomas induced by 1-methyl-1-nitrosourea. Breast Cancer Res Treat (2001) 0.83
Use of three-dimensional ultrasonography for prenatal diagnosis of ambiguous genitalia. J Ultrasound Med (2001) 0.83
Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice. Int J Oncol (2001) 0.83
Comparative pharmacodynamics of CYP2B induction by DDT, DDE, and DDD in male rat liver and cultured rat hepatocytes. J Toxicol Environ Health A (1998) 0.83
Mechanistic considerations in the evaluation of chemopreventive data. IARC Sci Publ (1996) 0.82
Inhibition of cigarette smoke-related lipophilic DNA adducts in rat tissues by dietary oltipraz. Carcinogenesis (1998) 0.82
Chronic/subacute total occlusion of the left main coronary artery--a case report and review of literature. Angiology (1999) 0.82
The role of 3-OH benzo(a)pyrene in mediating benzo(a)pyrene induced toxicity and transformation in cell culture. Res Commun Chem Pathol Pharmacol (1973) 0.82
Prospective multicenter study of second-trimester nuchal skinfold thickness in unaffected and Down syndrome pregnancies. Obstet Gynecol (1994) 0.82
Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice. Carcinogenesis (2001) 0.82
Post-surgical recovery and time-of-day mask potentiated responses of ACTH to repeated moderate hemorrhage in conscious rats. J Endocrinol (2000) 0.82
In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. Drug Metab Dispos (1997) 0.82
Prevention of lung cancer progression by bexarotene in mouse models. Oncogene (2006) 0.81
Effect of low caloric diet on endogenous carbon monoxide production: normal adults and Gilbert's syndrome. Proc Soc Exp Biol Med (1973) 0.81
Resolution of hydrops fetalis despite persistent fetal tachycardia. J Ultrasound Med (2001) 0.81
Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone. Anticancer Res (1994) 0.81
Mechanistic considerations in chemopreventive drug development. J Cell Biochem Suppl (1994) 0.81
Fetal echogenic bowel: parameters to be considered in differential diagnosis. Ultrasound Obstet Gynecol (2000) 0.81
Clinical development plan: N-Acetyl-l-cysteine. J Cell Biochem Suppl (1994) 0.81
Inhibition of cigarette smoke-related DNA adducts in rat tissues by indole-3-carbinol. Mutat Res (2000) 0.81
Induction of various cytochromes CYP2B, CYP2C and CYP3A by phenobarbitone in non-human primates. Pharmacogenetics (1992) 0.81
Farnesyl protein transferase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev (1997) 0.80
Relationship between DNA strand breaks and inhibition of poly (ADP-ribosylation): enhancement of carcinogen-induced transformation. Carcinogenesis (1986) 0.80
Three-dimensional ultrasonography in obstetrics and gynecology: preliminary experience. Am J Obstet Gynecol (1998) 0.80
Inherited susceptibility and acquired allelic imbalance in rat mammary carcinogenesis. J Cell Biochem Suppl (1996) 0.79
An interlaboratory comparison of transformation in Syrian hamster embryo cells with model and coded chemicals. Environ Mutagen (1986) 0.79
Effect of calcium on azoxymethane-induced aberrant crypt foci and cell proliferation in the colon of rats. Cancer Lett (1998) 0.79
Potential use of lipoxygenase inhibitors for cancer chemoprevention. Expert Opin Investig Drugs (2000) 0.79
Perspectives and progress in development of breast cancer chemopreventive drugs. Prog Clin Biol Res (1997) 0.79
Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary. J Cell Biochem Suppl (1995) 0.79
Clinical development plan: N-(4-hydroxyphenyl)retinamide. J Cell Biochem Suppl (1994) 0.79
Transvaginal ultrasound: does it help in the diagnosis of placenta previa? Ultrasound Obstet Gynecol (1992) 0.79
Progress in clinical chemoprevention. Semin Oncol (1997) 0.79
Induction of alopecia in mice exposed to cigarette smoke. Toxicol Lett (2000) 0.79